Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #21,651 to #21,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Osteochondroma differential diagnosis [9,082 bytes]
  2. (hist) Uterine polyp [9,082 bytes]
  3. (hist) Vesicoureteral reflux [9,081 bytes]
  4. (hist) YES1 [9,081 bytes]
  5. (hist) Migraine (Classification) [9,081 bytes]
  6. (hist) Weak central coherence theory [9,081 bytes]
  7. (hist) Simeprevir clinical pharmacology [9,080 bytes]
  8. (hist) Atopic dermatitis risk factors [9,080 bytes]
  9. (hist) Omega-3-Carboxylic Acids [9,079 bytes]
  10. (hist) EVL [9,079 bytes]
  11. (hist) Ethyl loflazepate [9,079 bytes]
  12. (hist) List of IARC Group 2B carcinogens [9,079 bytes]
  13. (hist) Robinow syndrome [9,079 bytes]
  14. (hist) Cirrhosis other diagnostic studies [9,077 bytes]
  15. (hist) CRX (gene) [9,077 bytes]
  16. (hist) Adenocarcinoma of the lung overview [9,076 bytes]
  17. (hist) Mountain rescue in England and Wales [9,076 bytes]
  18. (hist) Wikipedia:Naming conventions (long lists) [9,076 bytes]
  19. (hist) Spirometry [9,076 bytes]
  20. (hist) Hirsuties coronae glandis [9,075 bytes]
  21. (hist) Matthew effect [9,075 bytes]
  22. (hist) CRYGS [9,075 bytes]
  23. (hist) CREB3 [9,075 bytes]
  24. (hist) IRF6 [9,075 bytes]
  25. (hist) Periplakin [9,074 bytes]
  26. (hist) Familial adenomatous polyposis differential diagnosis [9,074 bytes]
  27. (hist) CRYGB [9,074 bytes]
  28. (hist) Jon Sudbø [9,074 bytes]
  29. (hist) CAMK2B [9,073 bytes]
  30. (hist) HCLS1 [9,073 bytes]
  31. (hist) SeHCAT [9,072 bytes]
  32. (hist) Vertebrobasilar insufficiency natural history, complications and prognosis [9,072 bytes]
  33. (hist) Robert Koch [9,072 bytes]
  34. (hist) RAMP2 [9,071 bytes]
  35. (hist) Medullary thyroid cancer (patient information) [9,071 bytes]
  36. (hist) Atopic dermatitis overview [9,071 bytes]
  37. (hist) SLC28A2 [9,071 bytes]
  38. (hist) Hybrid open access journal [9,070 bytes]
  39. (hist) Malnutrition [9,070 bytes]
  40. (hist) Tuberculosis Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis (ATS 2025 Guidelines) [9,069 bytes]
  41. (hist) Intra-cranial hypertension [9,069 bytes]
  42. (hist) Cefuroxime dosage and administration [9,069 bytes]
  43. (hist) Paraneoplastic syndrome differential diagnosis [9,069 bytes]
  44. (hist) SNTA1 [9,069 bytes]
  45. (hist) Preotact [9,069 bytes]
  46. (hist) GC (gene) [9,068 bytes]
  47. (hist) Copper(II) sulfate [9,068 bytes]
  48. (hist) Hypermobility [9,068 bytes]
  49. (hist) Myotonic dystrophy protein kinase [9,067 bytes]
  50. (hist) Multiple endocrine neoplasia [9,067 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)